Fundz

Vetmab Biosciences reported raising $575,000 in an initial SEC Form D filing, from an offering of $5 Million

PRIVATEDec 05, 2023

Amount Raised

$575,000

$575,000 sold, per SEC Form D (first sale Nov 21, 2023)

Round Type

Seed

San DiegoBiotechnology

Who to call at Vetmab Biosciences, Inc., and when

A new round usually means Vetmab Biosciences, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vetmab Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vetmab Biosciences, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vetmab Biosciences, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vetmab Biosciences, Inc.

Location

58 W. PORTAL AVE. #105

San Diego, California, United States

About

VETmAb BIO is a veterinary biopharmaceutical company focused on developing monoclonal antibodies ("mAbs") to treat debilitating diseases in dogs and cats. While monoclonal antibodies have provided revolutionary treatments in humans, mAbs technology has been underdeveloped in veterinary medicine. At VETmAb BIO, we’re taking advantage of human-validated targets and designing them specifically for dogs and cats, thereby mitigating technical risk. By utilizing our proprietary technologies, we can explore potential treatments to address various unmet needs in veterinary medicine.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vetmab Biosciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsDenise B., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Vetmab Biosciences, Inc.'s next move

See what Strategic adds

Vetmab Biosciences, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.